# A charge density wave-like instability in a doped spin-orbit-assisted weak Mott insulator

Preprint · H. Chu, L. Zhao, A. de la Torre, T. Hogan, S. D. Wilson, D. Hsieh

- Archive id: arxiv:1701.05194
- Published: 2017-01-18
- Venue: Nature Materials 16, 200-203 (2017)
- DOI: https://doi.org/10.1038/nmat4836
- arXiv: https://arxiv.org/abs/1701.05194
- Source URL: https://arxiv.org/abs/1701.05194
- PDF: https://arxiv.org/pdf/1701.05194
- Provenance: arxiv

## Abstract

Layered perovskite iridates realize a rare class of Mott insulators that are predicted to be strongly spin-orbit coupled analogues of the parent state of cuprate high-temperature superconductors. Recent discoveries of pseudogap, magnetic multipolar ordered and possible $d$-wave superconducting phases in doped Sr$\_2$IrO$\_4$ have reinforced this analogy among the single layer variants. However, unlike the bilayer cuprates, no electronic instabilities have been reported in the doped bilayer iridate Sr$\_3$Ir$\_2$O$\_7$. Here we show that Sr$\_3$Ir$\_2$O$\_7$ realizes a weak Mott state with no cuprate analogue by using ultrafast time-resolved optical reflectivity to uncover an intimate connection between its insulating gap and antiferromagnetism. However, we detect a subtle charge density wave-like Fermi surface instability in metallic electron doped Sr$\_3$Ir$\_2$O$\_7$ at temperatures ($T\_{DW}$) close to 200 K via the coherent oscillations of its collective modes, which is reminiscent of that observed in cuprates. The absence of any signatures of a new spatial periodicity below $T\_{DW}$ from diffraction, scanning tunneling and photoemission based probes suggests an unconventional and possibly short-ranged nature of this density wave order.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.